Stratec (ETR:SBS) Stock Price Up 0.4% – Time to Buy?
by Michael Walen · The Markets DailyStratec SE (ETR:SBS – Get Free Report) shares rose 0.4% on Friday. The company traded as high as €22.60 and last traded at €22.60. Approximately 6,930 shares changed hands during mid-day trading, an increase of 11% from the average session volume of 6,253 shares. The stock had previously closed at €22.50.
Stratec Stock Performance
The firm has a fifty day moving average of €22.13 and a 200-day moving average of €19.44. The company has a quick ratio of 1.65, a current ratio of 4.23 and a debt-to-equity ratio of 48.53. The stock has a market capitalization of $271.51 million, a price-to-earnings ratio of 27.12, a PEG ratio of 10.43 and a beta of 0.84.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
See Also
- Five stocks we like better than Stratec
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale